Sante publique (Vandoeuvre-les-Nancy, France) · 2026
[Not Available].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Magnez Pauline, Teigné Delphine, Fournier Jean-Pascal
Аннотация
OBJECTIVES: To assess the implementation of the “Renewal of treatment for allergic rhino-conjunctivitis by community pharmacists” cooperation protocol in a multiprofessional medical home using four indicators—usefulness, efficiency, safety, and satisfaction—six months after implementation.
METHODS: The intervention was carried out between April and November 2023. General practitioners and pharmacists/pharmacy assistants were invited to participate in the protocol. Inclusion criteria for patients were being between 15 and 50 years old, followed by a general practitioner affiliated with the medical home, and having a diagnosis of allergic rhinitis with a corresponding medication prescription. Usefulness was assessed as the proportion of patients managed by delegated professionals; efficiency, as the proportion of patients for whom the delegating general practitioner resumed follows-up; safety, as the occurrence of adverse events; and satisfaction, as assessed among professionals and patients.
RESULTS: Nine delegating general practitioners and 12 delegated pharmacists/pharmacy assistants participated in the protocol. Thirty-one patients were included and followed. Indicator results were 42.8% (usefulness), 87.1% (efficiency), 100% (safety), and 100% (satisfaction). Implementation of the protocol was limited in scope and by the complexity of administrative follow-up.
CONCLUSION: The protocol “Renewal of treatment for allergic rhino-conjunctivitis in pharmacies” is feasible and should be maintained, with consideration given to simplifications.
METHODS: The intervention was carried out between April and November 2023. General practitioners and pharmacists/pharmacy assistants were invited to participate in the protocol. Inclusion criteria for patients were being between 15 and 50 years old, followed by a general practitioner affiliated with the medical home, and having a diagnosis of allergic rhinitis with a corresponding medication prescription. Usefulness was assessed as the proportion of patients managed by delegated professionals; efficiency, as the proportion of patients for whom the delegating general practitioner resumed follows-up; safety, as the occurrence of adverse events; and satisfaction, as assessed among professionals and patients.
RESULTS: Nine delegating general practitioners and 12 delegated pharmacists/pharmacy assistants participated in the protocol. Thirty-one patients were included and followed. Indicator results were 42.8% (usefulness), 87.1% (efficiency), 100% (safety), and 100% (satisfaction). Implementation of the protocol was limited in scope and by the complexity of administrative follow-up.
CONCLUSION: The protocol “Renewal of treatment for allergic rhino-conjunctivitis in pharmacies” is feasible and should be maintained, with consideration given to simplifications.